Elite Health Systems Inc.

Overview

Compare with BioCorRx Inc., Concentra Group Holdings Parent, Inc. or Acadia Healthcare, or pick any stock.

• TickerEHSI on OTC¹
• IndustryServices-Specialty Outpatient Facilities, NEC¹
• HeadquartersOntario, California¹
• Incorporated inDE²
• Business address1131 W 6Th Street, Suite 225, Ontario, Ca 91762²
• Filer categoryNon-accelerated filer, Smaller reporting company²
• Legal formCorporation

See how the biggest companies compare on our leaderboards

Elite Health Systems Inc (the “Company”) is developing Medicare Advantage plans and offering other healthcare related services with a focus on improving and providing access to healthcare, primarily to senior and special needs groups in selected locations. The Company operates through its wholly owned subsidiaries, Elite Health Plan, Inc. (“Elite Health”) and Physician Support Systems Inc. (“PSS”).⁴ From its latest annual report

Corporate structure

Elite Health Systems Inc. sits at the top of its group. 6 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Elite Health Systems Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Investments

Intangibles and goodwill

Properties, in its own words

Until January 2024, the Company's executive offices were located in Rockville, MD. The Company’s headquarters are now located in, Ontario, CA where it conducts substantially all of its administrative operations in offices it shares with its wholly-owned subsidiary, Elite Health Plan, Inc.

Item 2 of the 10-K filed Apr 15, 2026.⁴

Leadership

Who has led Elite Health Systems Inc., and when. Pick a name to see everywhere that person has worked.

• Chief executive officerPrasad Anjaneya Jeereddi Nov 6, 2024 to now¹⁵
• Chief financial officerKenneth A. Minor Jul 31, 2025 to now¹⁶

Named in SEC Form D filings

People the company listed in its private-offering notices.

• DirectorAlan Gold named Dec 5, 2024 to Jul 31, 2025²⁰
• DirectorHaranath F. Policherla named Jul 31, 2025²⁰
• DirectorWilliam F. St. Lawrence named Dec 5, 2024 to Jul 31, 2025²⁰

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

• Elite Health Plan of Nevada, Inc. Nevada³
• Elite Health Plan, Inc. California³
• Elite Systems Holdings Inc. Delaware³
• Physician Support Systems Inc, California³
• USN Corona, Inc. Delaware³

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

• Elite Health Systems, Inc.Oct 3, 2024 to Oct 3, 2024²
• U.S. NeuroSurgical Holdings, Inc.Sep 3, 2015 to Aug 9, 2024²
• US NEUROSURGICAL INCAug 10, 1999 to Aug 14, 2015²

Timeline

1. Aug 5, 20268-K Entered a material agreement²¹
2. Jul 10, 20268-K Other events²²
3. Nov 5, 20258-K Shareholder vote²³
4. Sep 29, 20258-K Entered a material agreement²⁴
5. Sep 2, 20258-K Entered a material agreement²⁵
6. Jul 31, 20258-K Executive or director change²⁶
7. Jul 3, 20258-K Unregistered sale of shares; Other events²⁷
8. Jun 9, 20258-K Entered a material agreement²⁸
9. Jun 5, 20258-K Entered a material agreement²⁹
10. May 30, 20258-K Entered a material agreement³⁰
11. Dec 2, 20248-K Entered a material agreement; Other events³¹
12. Nov 6, 2024New chief executive Prasad Anjaneya Jeereddi becomes CEO¹⁵
13. Oct 3, 20248-K Bylaws or fiscal year changed; Other events³²

Filings

87 filings to the SEC since October 2021: 7 annual reports, 16 quarterly reports, 20 major events, 21 insider forms, 3 large holders, 5 private raises, 15 other. The latest 20:

1. Sep 9, 20264 EDGAR
2. Aug 19, 202610-Q EDGAR
3. Aug 14, 2026NT 10-Q EDGAR
4. Aug 5, 20268-K EDGAR
5. Aug 4, 20264 EDGAR
6. Jul 10, 20268-K EDGAR
7. Jul 9, 20264 EDGAR
8. Jun 9, 20264 PRIMARY DOCUMENT EDGAR
9. May 20, 202610-Q EDGAR
10. May 15, 2026NT 10-Q EDGAR
11. May 13, 20264 PRIMARY DOCUMENT EDGAR
12. Apr 15, 202610-K EDGAR
13. Apr 1, 2026NT 10-K EDGAR
14. Jan 8, 20264 EDGAR
15. Dec 29, 2025SCHEDULE 13D EDGAR
16. Dec 3, 20254 EDGAR
17. Nov 13, 202510-Q EDGAR
18. Nov 5, 20258-K EDGAR
19. Sep 29, 2025DEF 14A EDGAR
20. Sep 29, 20258-K EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

9 open-market trades by officers, directors and large owners since October 2021: 9 buys and 0 sales. Grants, option exercises and gifts are left out.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• Prasad Anjaneya JeereddiSCHEDULE 13D, 2 filings Dec 5, 2023 to Dec 29, 2025³³
• ALLEN HOLDING INC /NYSCHEDULE 13G, 1 filing Feb 26, 2025³⁴

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

Money raised

Private offerings the company reported to the SEC on Form D.

1. Jul 31, 2025Filed a private offering of equity Form D: $5 million offered in all Form D
2. Jan 16, 2024Raised $5 million in a private offering of equity Form D: $5.5 million offered in all Form D

SEC filer profile

How Elite Health Systems Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARElite Health Systems Inc.¹
• CIK0001089815
• Employer ID (EIN)47-5370333⁴
• Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company⁴
• Incorporated inDelaware⁴
• Fiscal year endsDecember 31¹
• Industry code (SIC)8093 Services-Specialty Outpatient Facilities, NEC¹
• SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance¹
• Business address1131 W 6Th Street, Suite 225, Ontario, CA 91762¹
• Phone949-249-1170¹
• Shares outstanding28,521,620 as of Aug 19, 2026⁶
• Public float$23.9M as of Jun 30, 2025⁴
• AuditorMercurius & Associates LLP, New Delhi, India PCAOB ID 3233; no auditor attestation of internal control over financial reporting⁴
• On EDGAR sinceJul 1, 1999¹
• Filings227 in all: 10-Q (73), 10-K (25), 8-K (25), 4 (20), NT 10-K (12), NT 10-Q (10), 10QSB (8), CORRESP (7)¹
  All 27 form types

  UPLOAD (7), 10-Q/A (6), 10-K/A (4), 5 (4), SC 13G/A (4), 3 (3), D/A (3), 10-12G/A (2), 10KSB (2), D (2), SC 13D (2), 10-12G (1), 8-K/A (1), 8-K12G3 (1), DEF 14A (1), PRE 14A (1), SC 13G (1), SCHEDULE 13D (1), SCHEDULE 13G (1)

• Latest filingsAnnual report (10-K) Apr 15, 2026
  Quarterly report (10-Q) Aug 19, 2026
  Proxy statement (DEF 14A) Sep 29, 2025
  Latest 8-K (8-K) Aug 5, 2026

Risk factors and legal proceedings

The risks Elite Health Systems Inc. names in Item 1A of its 10-K filed Apr 15, 2026: 28 risks under these headings, as written.⁴

• RISKS RELATED TO OUR BUSINESS
• The principal business activity of the Company going forward will be the development of Medical Advantage plans under its Elite Health subsidiaries. This is a new business area for the Company and there can be no assurance that the Company will be successful in advancing its Elite Health business.
• Although we raised sufficient capital to achieve our license and launch our Medicare Advantage plan, we will require additional capital, which might not be available on acceptable terms, if at all. If capital is not available to us, our business and financial condition may be impaired, and we may not be able to continue as a going concern.
• If we are unable to maintain a Medicare Advantage license in California, acquire sufficient managed health consumers in California, expand consumer enrollment beyond this initial state, or diversify and expand our portfolio of products and services, our business and results of operations will be significantly impaired.
• We are subject to risks associated with outsourcing services and functions to third parties. If we are unsuccessful in securing reliable third parties, or if we experience negative outcomes through these parties, our business may be substantially impacted.
• We operate in highly competitive markets dominated by large providers with significantly more resources than ourselves.
• If we or one of our significant vendors sustain a cyber-attack or suffer data privacy or security breaches that disrupt our information systems or operations, or result in the dissemination of sensitive personal or confidential information, we could suffer increased costs, exposure to significant liability, reputational harm, loss of business, and other serious negative consequences.
• Failure to appropriately set premiums or effectively manage our costs could negatively affect our profitability, results of operations and cash flows.
• The costs associated with the launch and development of Medical Advantage plans by our Elite Health business or failure to attain profitability in any newly launched or acquired businesses could negatively affect our results of operations.
• We will primarily depend on reimbursement by third-party payors, as well as payments by individuals, which could lead to delays, uncertainties and disagreements regarding the timing and process of reimbursement, including any changes or reductions in Medicare reimbursement rates or rules.
• Our health plans are subject to risk associated with various contractual provisions and regulations establishing medical cost expenditure floors, profit ceilings, risk corridors, and quality withholds.
• If we fail to accurately predict and effectively manage our medical care costs, our operating results could be materially and adversely affected.

Legal proceedings

The Company is subject to lawsuits, investigations and potential claims arising out of the ordinary conduct of its business. The Company is not currently involved in any material litigation.

The opening of Item 3, Legal Proceedings.⁴